PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD

2013-11-19
(Press-News.org) Contact information: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences
In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD (SALT LAKE CITY)—Drugs known as PDE3 inhibitors save many lives by helping failing hearts do a better job of pumping blood. But those same medications come with a sometimes deadly cost when taken for long periods: an increased risk for sudden cardiac death.

The drugs work by inhibiting PDE3A, an enzyme that regulates how the heart pumps blood. When PDE3A is inhibited, the heart contracts more forcefully, pumping more blood.

Developing a medication that has the benefits of current drugs but doesn't increase the risk for sudden cardiac death associated has eluded researchers. But an international collaboration led by two Utah researchers is a key first step in finding out whether such a drug may one day be developed.

The research, funded by the Department of Veterans Affairs, was published in the Proceedings of the National Academy of Sciences (PNAS) online the week of Nov. 18, 2013. Matthew A. Movsesian, M.D., professor of medicine at the University of Utah School of Medicine and a cardiologist at the George E. Wahlen Department of Veterans Affairs Medical Center in Salt Lake City, is the senior author. Fabrice Vandeput, Ph.D., a postdoctoral fellow in cardiology at the University of Utah and the VA Medical Center, is first author.

PDE3A comes in three types, or isoforms. PDE3A inhibitors work by inhibiting all three isoforms of the enzyme. Working with colleagues from the United States and Scotland, Vandeput and Movsesian made an important discovery: two of those isoforms, PDE3A1 and PDE3A2, are regulated individually and interact with different proteins in a cell.

"If those isoforms are regulated differently, this tells us they probably are doing different things in cells. And if they interact with different proteins, this means there are molecules that bind to one isoform and not the other," Movsesian says.

That could make it possible to develop a drug that targets one or other of the isoforms to inhibit PDE3A without upping the risk of sudden cardiac death. Years of work must be done before such a drug could be developed and available to heart failure patients. Researchers need to learn much more about the isoforms to understand their roles in how the heart contracts to pump blood (called contractility). They also need to know whether either form of PDE3A contributes to sudden cardiac death in those taking current drugs.

It's also possible that research could determine neither of the isoforms would be a good target for drugs, according to Movsesian, also a professor of pharmacology and toxicology.

"We don't know for certain if these isoforms will ultimately prove to be good targets for drugs," he says. "But we now have reason to believe we could target one or the other."

About 5.7 million people in the United States have heart failure, according to the Centers for Disease Control and Prevention (CDC), with more than 55,000 deaths directly attributed to the condition annually. In 2008, heart failure was a contributing cause in 280,000 deaths, according to the CDC.

PDE3 inhibitors can be taken for shorter periods, when someone has a heart attack and needs help recovering, for example, or for a year or more, such as when a patient with heart failure waits for a transplant or can't survive without the drug. In patients who take them for longer periods, an increase in the mortality rate from sudden cardiac death may outweigh the benefits of increasing cardiac contractility, according to Movsesian.

### END


ELSE PRESS RELEASES FROM THIS DATE:

National study finds renal stenting does not improve outcomes for renal artery stenosis patients

2013-11-19
National study finds renal stenting does not improve outcomes for renal artery stenosis patients Rhode Island Hospital researchers play lead roles in study; will present findings at the annual meeting of the American Heart Association PROVIDENCE, R.I. – According to the findings ...

2 studies on the use of breast MRI

2013-11-19
2 studies on the use of breast MRI CHICAGO – The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine, a JAMA ...

Beta-blockers before surgery appear associated with lower risk of heart-related events

2013-11-19
Beta-blockers before surgery appear associated with lower risk of heart-related events Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) ...

Poorer, rural counties have lower CPR training rates

2013-11-19
Poorer, rural counties have lower CPR training rates Cardiopulmonary resuscitation (CPR) training appears to be lower in more rural counties, those with higher proportions of black and Hispanic residents and lower household incomes, and in the South, Midwest ...

Drinking more milk as a teenager does not lower risk of hip fracture later

2013-11-19
Drinking more milk as a teenager does not lower risk of hip fracture later Drinking more milk as a teenager apparently does not lower the risk of hip fracture as an older adult and instead appears to increase that risk for men, according to a study published by ...

Preterm birth risk increases for pregnant women exposed to phthalates

2013-11-19
Preterm birth risk increases for pregnant women exposed to phthalates The odds of preterm delivery appear to increase for pregnant women exposed to phthalates, chemicals people are exposed to through contaminated food and water and in a variety of products ...

Gene plays major role in suppressing cancer

2013-11-19
Gene plays major role in suppressing cancer Adelaide researchers have found that a specific gene plays an important role in suppressing lymphoma, a type of blood cell cancer. The caspase-2 gene is related to a family of proteins that are essential for ...

Tackling early socioeconomic inequality as important as encouraging smoking cessation

2013-11-19
Tackling early socioeconomic inequality as important as encouraging smoking cessation Although health behaviours such as smoking are directly linked to the majority of early deaths in the UK, tackling these individual factors fails to address the underlying ...

Bacteria recycle broken DNA

2013-11-19
Bacteria recycle broken DNA Bacteria recycle broken DNA that bacteria can take up small as well as large pieces of old DNA from this scrapheap and include it in their own genome. This discovery may have major consequences – both in connection ...

A vexing math problem finds an elegant solution

2013-11-19
A vexing math problem finds an elegant solution ITHACA, N.Y. – A famous math problem that has vexed mathematicians for decades has met an elegant solution by Cornell University researchers. Graduate student Yash Lodha, working with Justin Moore, professor of mathematics, ...

LAST 30 PRESS RELEASES:

Study confirms that people with ADHD can be more creative. The reason may be that they let their mind wander

Research gives insight into effect of neurodegenerative diseases on speech rhythm

Biochar and plants join forces to clean up polluted soils and boost ecosystem recovery

Salk scientist Joseph Ecker awarded McClintock Prize for Plant Genetics and Genome Studies

ADHD: Women are diagnosed five years later than men, despite symptoms appearing at the same age.

Power plants may emit more pollution during government shutdowns

Increasing pressures for conformity de-skilling and demotivating teachers, study warns

Researchers develop smarter menstrual product with potential for wearable health monitoring

Microwaves for energy-efficient chemical reactions

MXene current collectors could reduce size, improve recyclability of Li-ion batteries

Living near toxic sites linked to aggressive breast cancer

New discovery could open door to male birth control

Wirth elected Fellow of American Physical Society

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: October 10, 2025

Destined to melt

Attitudes, not income, drive energy savings at home

The playbook for perfect polaritons

‘Disease in a dish’ study of progressive MS finds critical role for unusual type of brain cell

Solar-powered method lights the way to a ‘de-fossilized’ chemical industry

Screen time linked to lower academic achievement among Ontario elementary students

One-year outcomes after traumatic brain injury and early extracranial surgery in the TRACK-TBI Study

Enduring outcomes of COVID-19 work absences on the US labor market

Affirmative action repeal and racial and ethnic diversity in us medical school admissions

Cancer progression illuminated by new multi-omics tool

Screen time and standardized academic achievement tests in elementary school

GLP-1RA order fills and out-of-pocket costs by race, ethnicity, and indication

Study finds HEPA purifiers alone may not be enough to reduce viral exposure in schools

UVA Health developing way to ID people at risk of dangerous lung scarring even before symptoms appear

How can we know when curing cancer causes myocarditis?

Male infertility in Indian men linked to lifestyle choices and hormonal imbalances

[Press-News.org] In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD